IRMD Iradimed Corp

Price (delayed)

$34.46

Market cap

$424.29M

P/E Ratio

430.75

Dividend/share

N/A

EPS

$0.08

Enterprise value

$376.14M

Highlights
Iradimed's quick ratio has increased by 13% YoY and by 7% from the previous quarter
Iradimed's equity has increased by 9% YoY and by 2.8% QoQ
The gross profit is down by 19% YoY but it is up by 2.5% QoQ
IRMD's price to earnings (P/E) is 177% higher than its last 4 quarters average of 155.4
Iradimed's net income has plunged by 90% YoY and by 28% from the previous quarter

Key stats

What are the main financial stats of IRMD
Market
Shares outstanding
12.31M
Market cap
$424.29M
Enterprise value
$376.14M
Valuations
Price to earnings (P/E)
430.75
Price to book (P/B)
6.73
Price to sales (P/S)
13.15
EV/EBIT
1,180.13
EV/EBITDA
228.72
EV/Sales
11.66
Earnings
Revenue
$32.26M
EBIT
$318,728
EBITDA
$1.64M
Free cash flow
$4.98M
Per share
EPS
$0.08
Free cash flow per share
$0.4
Book value per share
$5.12
Revenue per share
$2.62
TBVPS
$5.78
Balance sheet
Total assets
$72.19M
Total liabilities
$9.11M
Debt
$2.65M
Equity
$63.08M
Working capital
$60.58M
Liquidity
Debt to equity
0.04
Current ratio
14.07
Quick ratio
12.36
Net debt/EBITDA
-29.28
Margins
EBITDA margin
5.1%
Gross margin
74.9%
Net margin
3.1%
Operating margin
0.9%
Efficiency
Return on assets
1.4%
Return on equity
1.6%
Return on invested capital
1.7%
Return on capital employed
0.5%
Return on sales
1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

IRMD stock price

How has the Iradimed stock price performed over time
Intraday
-0.86%
1 week
2.29%
1 month
22.81%
1 year
45.09%
YTD
51.14%
QTD
17.17%

Financial performance

How have Iradimed's revenue and profit performed over time
Revenue
$32.26M
Gross profit
$24.17M
Operating income
$283,680
Net income
$986,639
Gross margin
74.9%
Net margin
3.1%
Iradimed's operating margin has surged by 138% QoQ but it has shrunk by 96% YoY
The company's operating income has surged by 138% QoQ but it has shrunk by 96% YoY
Iradimed's net income has plunged by 90% YoY and by 28% from the previous quarter
The company's net margin has shrunk by 87% YoY and by 28% QoQ

Growth

What is Iradimed's growth rate over time

Valuation

What is Iradimed stock price valuation
P/E
430.75
P/B
6.73
P/S
13.15
EV/EBIT
1,180.13
EV/EBITDA
228.72
EV/Sales
11.66
IRMD's price to earnings (P/E) is 177% higher than its last 4 quarters average of 155.4
Iradimed's EPS has shrunk by 90% YoY and by 33% QoQ
The price to book (P/B) is 43% higher than the last 4 quarters average of 4.7 and 35% higher than the 5-year quarterly average of 5.0
Iradimed's equity has increased by 9% YoY and by 2.8% QoQ
The price to sales (P/S) is 85% higher than the 5-year quarterly average of 7.1 and 55% higher than the last 4 quarters average of 8.5
The company's revenue fell by 17% YoY

Efficiency

How efficient is Iradimed business performance
Iradimed's return on invested capital has surged by 155% QoQ but it has shrunk by 96% YoY
Iradimed's return on sales has surged by 153% QoQ but it has shrunk by 95% YoY
Iradimed's return on equity has shrunk by 91% YoY and by 30% QoQ
The company's return on assets has shrunk by 91% YoY and by 30% QoQ

Dividends

What is IRMD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for IRMD.

Financial health

How did Iradimed financials performed over time
The current ratio is up by 13% year-on-year and by 9% since the previous quarter
Iradimed's quick ratio has increased by 13% YoY and by 7% from the previous quarter
The company's debt is 96% lower than its equity
The debt to equity has decreased by 20% YoY
Iradimed's equity has increased by 9% YoY and by 2.8% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.